IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Goldline Pharmaceutical IPO is a Book Building IPO listing on BSE SME exchange, with an ipo size of ₹ [●] Cr. The company is based in Nagpur and caters to Pharmaceutical sector. Cumulative Capital is the merchant banker of Goldline Pharmaceutical IPO. It is a SME Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 30th September 2025.
IPO
Size:
₹ Cr.
Avg IPO Size (Sector Based)
: ₹
21.71 cr.
Sector: Pharmaceutical
SME
IPO so far:
42
Merchant Banker:
Cumulative Capital
SME
IPO by BRLM so far:
3
City:
Nagpur
SME
IPO so far:
18
Revenue (annualised):
₹
28.06
cr. 
PE
Ratio:
x
Average Sector PE Ratio: 20.39x
Goldline Pharmaceutical IPO size is ₹ [●] with IPO price of ₹ [●]. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
| Particulars | Amount |
|---|---|
| General corporate purposes | [●] |
Cumulative Capital Private Limited is the book-running lead manager of the Goldline Pharmaceutical IPO. Bigshare Services Private Limited is the Registrar for Goldline Pharmaceutical IPO.
Goldline Pharmaceutical IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Goldline Pharmaceutical IPO, based in Nagpur, operates in the Pharmaceutical sector with a focus on Engaged in the business of marketing pharmaceutical products. The company is launching its SME Upcoming IPO on the BSE SME exchange, using the Book Building Issue method. Goldline Pharmaceutical IPO size is ₹ [●] with fresh issue size of ₹ 0 Cr. and Offer for sale being ₹ Nil
The IPO allotment date for Goldline Pharmaceutical IPO is expected to be [●], after the finalization of basis of allotment. Investors can check Goldline Pharmaceutical IPO allotment status on the registrars website, Bigshare Services Private Limited . Goldline Pharmaceutical IPO refund dates are [●].
Goldline Pharmaceutical IPO is expected to be listed on [●].
The upper price band for the Goldline Pharmaceutical IPO is set at ₹ [●] per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Goldline Pharmaceutical IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Goldline Pharmaceutical IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of [●]. After submission, funds are blocked until the basis of allotment of Goldline Pharmaceutical IPO is finalised.
The merchant banker for Goldline Pharmaceutical IPO is Cumulative Capital Private Limited . Cumulative Capital Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Goldline Pharmaceutical IPO RHP for further details.
The registrar for Goldline Pharmaceutical IPO is Bigshare Services Private Limited . Investors can go to Bigshare Services Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Goldline Pharmaceutical IPO through their official website or helpline.
Goldline Pharmaceutical IPO was subscribed [●] times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
Get
Ready Image
IPO
Size:
[●]
Avg IPO Size (Sector Based)
:
₹ 21.71 Cr.
Sector: Pharmaceutical
SME
IPO so far:
42
Merchant Banker:
Cumulative Capital
SME
IPO by BRLM so far:
3
City:
Nagpur
SME
IPO so far:
18
Revenue (annualised):
₹ 28.06 cr.
PE
Ratio:
[●]
Average Sector PE Ratio: 20.39x
Goldline Pharmaceutical IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Goldline Pharmaceutical Financial Review Page
Merchant Banker(s) of Goldline Pharmaceutical IPO: Cumulative Capital Private Limited
Goldline Pharmaceutical IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Goldline Pharmaceutical IPO listed at a listing price of against the offer price of .
The current market price of Goldline Pharmaceutical is .
Why Us?
